The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-225

This is exactly the type of news PAA need to be the focus of.

If the first full round of data is as good as they're building it up to be, PAA should be all over every form of media with the news. Looking at that snippet, PAA is well ahead in the timeline....so that will be the new marketing team's time to shine!

While I'm here (nursing a hangover after school night drinking) - sellers taking a profit now seems odd, but I needed money for some solar vents last week - shares had to go...it happens.

Also while I'm here - a note of caution - mentioned above somewhere was a comment about being the new standard of treatment (which it appears we might be) - but this was also the case with the canine lymphoma results - which has gone nowhere (yes, I know - apples and oranges but the point remains).

I'm getting pretty antsy for these results to be released. Every day that passes is one day closer to the end of February...let's see how the new bloke goes in the missed timelines arena.

Continued GLTAH.